3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
38
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
10
Neoplasm Metastasis
7
Hodgkin Disease
6
Recurrence
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Carcinoma
2
Breast Neoplasms, Male
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Pleural Effusion, Malignant
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non - Small Cell Lung Cancer NSCLC
1
Neuroendocrine Tumors
1
Neuralgia
1
Metatropic dwarfism
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Locally Advanced Non-Small Cell Lung Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Glioma
1
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
Vinorelbine
×
Clear all
No trials found.